Thursday, November 13, 2008

Economic Crisis Presents an Opportunity for the Indian Pharma Outsourced Industry

This latest article on BioPharmaLife discusses how even though clinical trials in the US are going through a rough patch the Indian pharma outsourced industry is expected to thrive due to the economic crisis.

With many companies pulling back on investments, drug-makers are turning to India for cheaper resources for manufacturing and research. By the year 2011, the US is expected to have outsourced 65% of all its clinical trials to India.

No comments:

Post a Comment